Oncotelic Therapeutics (OTLC) Change in Accured Expenses (2010 - 2025)
Oncotelic Therapeutics' Change in Accured Expenses was -$256,854 in Q4 2025, compared with $81,889 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Change in Accured Expenses (2010 - 2025) Analysis & Trends
For FY2025, Change in Accured Expenses at Oncotelic Therapeutics came in at $103,711, down 64.6% from FY2024.
- Change in Accured Expenses shows a five-year compound annual growth rate of -31.4% (FY2020 to FY2025).
- In earlier years, Change in Accured Expenses was $293,174 in FY2024, -$72,771 in FY2023, $873,951 in FY2022 (+315.4%) and $210,371 in FY2021 (-69.1%).
- The Q4 2025 figure marks the lowest quarterly Change in Accured Expenses since Q4 2023.
- Compared with a year earlier, Change in Accured Expenses was higher in three of the last five quarters, with growth averaging 65.1%.
- The best year-over-year quarter for Change in Accured Expenses over five years was Q1 2021 (growth of 389.1%); the worst was Q3 2021 (a decline of 94.1%).
- Per Business Quant data, OTLC's Change in Accured Expenses in the three quarters before Q4 2025 was $155,661 (Q3 2025), $108,644 (Q2 2025) and $96,260 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | - |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -256,854.00 |
| Sep 30, 2025 | 155,661.00 |
| Jun 30, 2025 | 108,644.00 |
| Mar 31, 2025 | 96,260.00 |
| Dec 31, 2024 | 81,889.00 |
| Sep 30, 2024 | 98,179.00 |
| Jun 30, 2024 | 23,966.00 |
| Mar 31, 2024 | 89,140.00 |
| Dec 31, 2023 | -440,119.00 |
| Sep 30, 2023 | 250,059.00 |
| Jun 30, 2023 | -17,301.00 |
| Mar 31, 2023 | 134,590.00 |
| Dec 31, 2022 | 586,361.00 |
| Sep 30, 2022 | 10,886.00 |
| Jun 30, 2022 | -87,796.00 |
| Mar 31, 2022 | 364,500.00 |
| Dec 31, 2021 | -1.39 Mn |
| Sep 30, 2021 | 11,257.00 |
| Jun 30, 2021 | 709,754.00 |
| Mar 31, 2021 | 879,838.00 |
API Access
Oncotelic Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();